SNY:NASDAQ
Sanofi SA
$42.68
arrow_downward
-0.63%(-0.27) 1D
$42.77
arrow_upward
+0.21% (+0.091)bedtimeAfter hours
Closed: Aug 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNY...
Open
$42.77
High
$42.90
Low
$42.54
Mkt. cap
103.07B
Avg. vol.
4.04M
Volume
2.26M
Dividend
5.67%
Quarterly dividend
$0.60
Ex-dividend date
May 5, 2026
P/E ratio
12.00
52-wk high
$52.68
52-wk low
$40.89
EPS
$3.56
Beta
0.38
Shares outstanding
2.42B
No. of employees
75K
Open
$42.77
High
$42.90
Low
$42.54
Mkt. cap
103.07B
Avg. vol.
4.04M
Volume
2.26M
Dividend
5.67%
Quarterly dividend
$0.60
Ex-dividend date
May 5, 2026
P/E ratio
12.00
52-wk high
$52.68
52-wk low
$40.89
EPS
$3.56
Beta
0.38
Shares outstanding
2.42B
No. of employees
75K
News stories
From sources across the web
FinancialContent
·
48 minutes ago
Amgen (NASDAQ:AMGN) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full-Year Sales
Investor's Business Daily
·
29 minutes ago
Dow Jones Futures: S&P 500 Jumps To High; SpaceX, AMD Lead Earnings Movers Late
StockStory
·
17 minutes ago
Marqeta’s (NASDAQ:MQ) Q2 CY2026 Sales Top Estimates But Quarterly Revenue Guidance Misses Expectations
CBS News
·
2 hours ago
Dow soars 900 points on strong corporate earnings and hopes of Iran deal
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson | Belén Garijo
Employees74.8K
Founded1973
HeadquartersParis, Île-de-France, France
SectorPharmaceutical industry
Websitesanofi.com
AI content may include mistakes. Learn more